Joseph Gebbia, a director at $ABNB, sold 185,696 shares of the company on 10-13-2025 for an estimated $22,164,284. We received data on the trade from a recent SEC filing. This was a sale of approximately 20.9% of their shares of this class of stock. Following this trade, they now own 704,015 shares of this class of $ABNB stock.
$ABNB Insider Trading Activity
$ABNB insiders have traded $ABNB stock on the open market 89 times in the past 6 months. Of those trades, 0 have been purchases and 89 have been sales.
Here’s a breakdown of recent trading of $ABNB stock by insiders over the last 6 months:
- JOSEPH GEBBIA has made 0 purchases and 48 sales selling 3,241,364 shares for an estimated $414,381,774.
- ELINOR MERTZ (Chief Financial Officer) has made 0 purchases and 6 sales selling 34,439 shares for an estimated $4,468,411.
- BRIAN CHESKY (CEO and Chairman) has made 0 purchases and 11 sales selling 24,500 shares for an estimated $3,356,320.
- ARISTOTLE N BALOGH (Chief Technology Officer) has made 0 purchases and 21 sales selling 13,675 shares for an estimated $1,750,125.
- DAVID C BERNSTEIN (Chief Accounting Officer) sold 5,000 shares for an estimated $710,000
- NATHAN BLECHARCZYK (Chief Strategy Officer) has made 0 purchases and 2 sales selling 4,491 shares for an estimated $582,096.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABNB Hedge Fund Activity
We have seen 611 institutional investors add shares of $ABNB stock to their portfolio, and 557 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 9,720,112 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,286,359,622
- HARRIS ASSOCIATES L P added 4,292,383 shares (+43.2%) to their portfolio in Q2 2025, for an estimated $568,053,966
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,557,068 shares (-81.0%) from their portfolio in Q2 2025, for an estimated $338,402,379
- JENNISON ASSOCIATES LLC removed 2,304,937 shares (-33.9%) from their portfolio in Q2 2025, for an estimated $305,035,362
- WELLINGTON MANAGEMENT GROUP LLP added 2,192,930 shares (+50.3%) to their portfolio in Q2 2025, for an estimated $290,212,356
- NUVEEN, LLC removed 1,934,084 shares (-63.0%) from their portfolio in Q2 2025, for an estimated $255,956,676
- AQR CAPITAL MANAGEMENT LLC removed 1,589,924 shares (-37.1%) from their portfolio in Q2 2025, for an estimated $210,410,542
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABNB Analyst Ratings
Wall Street analysts have issued reports on $ABNB in the last several months. We have seen 7 firms issue buy ratings on the stock, and 5 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 09/30/2025
- Jefferies issued a "Buy" rating on 08/11/2025
- Morgan Stanley issued a "Underweight" rating on 08/07/2025
- Barclays issued a "Underweight" rating on 08/07/2025
- Wells Fargo issued a "Underweight" rating on 08/07/2025
- Truist Securities issued a "Sell" rating on 05/30/2025
- Cantor Fitzgerald issued a "Underweight" rating on 05/14/2025
To track analyst ratings and price targets for $ABNB, check out Quiver Quantitative's $ABNB forecast page.
$ABNB Price Targets
Multiple analysts have issued price targets for $ABNB recently. We have seen 21 analysts offer price targets for $ABNB in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Lloyd Walmsley from Mizuho set a target price of $151.0 on 09/30/2025
- Patrick Scholes from Truist Securities set a target price of $104.0 on 09/03/2025
- John Colantuoni from Jefferies set a target price of $160.0 on 08/11/2025
- Brad Erickson from RBC Capital set a target price of $145.0 on 08/07/2025
- Trevor Young from Barclays set a target price of $105.0 on 08/07/2025
- Ken Gawrelski from Wells Fargo set a target price of $110.0 on 08/07/2025
- Brian Pitz from BMO Capital set a target price of $124.0 on 08/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
